PIER MARIA FORNASARI

PIER MARIA FORNASARI
2019-05-27

Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research

Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence generation Verily, an Alphabet company, today announced strategic alliances with Novartis, Otsuka, Pfizer Inc. and Sanofi to develop digitally innovative, patient-centered clinical research programs using Project Baseline’s evidence generation platform and tools. The Baseline Platform is designed

No Comments InDIGITAL HEALTH

PIER MARIA FORNASARI
2019-05-27

ICER Comments on the FDA Approval of Zolgensma for the Treatment of Spinal Muscular Atrophy

In light of additional data from ongoing trials of onasemnogene abeparvovec (Zolgensma®, Novartis/AveXis), as well as the treatment’s final FDA label and just-announced launch price, the Institute for Clinical and Economic Review (ICER) today published an addendum to its Final Evidence Report on treatments for spinal muscular atrophy (SMA). Since the publication of ICER’s Final Evidence Report on

No Comments InGENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2019-05-27

Healthcare in the year 2040

CEO Steven Collens shares his thoughts on what the healthcare system will look like 20 years from now. One day, a doctor will reach out to you before you even know you’re sick. That’s the future we see coming to life in the technologies emerging from the healthcare innovation community. One of the most interesting

No Comments InDIGITAL HEALTH

PIER MARIA FORNASARI
2019-05-27

Bioprinting in regenerative medicine

In the paper “Three‐Dimensional Bioprinting in Regenerative Medicine: Reality, Hype, and Future,” authors Anthony Atala and Gabor Forgacs explore some necessary topics within 3D printing and bioprinting. The technology has brought forth incredible innovation capable of transforming manufacturing, design mechanisms, and offering never dreamed of self-sustainability that could be even more useful in the future

No Comments InBIOPRINTING

PIER MARIA FORNASARI
2019-05-27

Proof It’s Possible to Enhance or Suppress Memories

Boston University neuroscientist shows that stimulating different parts of the brain can dial up or down a specific memory’s emotional oomph What if scientists could manipulate your brain so that a traumatic memory lost its emotional power over your psyche? Steve Ramirez (CAS’10), a Boston University neuroscientist fascinated by memory, believes that a small structure in the

No Comments InWELLNESS

PIER MARIA FORNASARI
2019-05-25

Newly approved Novartis gene therapy will be world’s most expensive drug

Source STAT he Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most expensive drug in the world. Known as Zolgensma, the gene therapy treats children under 2 years of age with spinal muscular atrophy, an

No Comments InGENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2019-05-25

How Europe will spend €100 billion in its next research programme

Source Nature One day before the last parliament dissolved, on 17 April, negotiators signed off on the general outlines of the union’s next giant research programme, known as Horizon Europe, which runs from 2021 to 2027. The EU’s much sought after multi-year research programmes support academic and commercial research across its 28 member states and

No Comments InUncategorized

PIER MARIA FORNASARI
2019-05-24

A new study uncovers how we evolved to benefit from eating fermented food

For thousand of years humans have been using fermentation as a way of preserving foods and engendering good gut health. A fascinating new study from scientists at the University of Leipzig has discovered that a specific immune function receptor, uniquely evolved in humans and great apes, is triggered by a metabolite from lactic acid bacteria

No Comments InWELLNESS

PIER MARIA FORNASARI
2019-05-24

Clinical updates in Regenerative Medicine

Source ARM Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s HElix Endocardial Delivery System Improved in Ejection Fraction and NYHA ClassMay 23, 2019 – (BioCardia) – At 12 months, patients with Helix-delivered cell therapy experienced a 7.33 percent imprvement in ejection fraction at 12 months compared to the control group. Helix patients

No Comments InREGENERATIVE MEDICINE

PIER MARIA FORNASARI
2019-05-24

Mobile phone app designed to boost physical activity in women shows promise

Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone app designed for inactive women did help when combined with an activity tracker and personal counseling. Researchers said the findings offer important clues about how

No Comments InDIGITAL HEALTH

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

All posts by PIER MARIA FORNASARI

Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research

ICER Comments on the FDA Approval of Zolgensma for the Treatment of Spinal Muscular Atrophy

Healthcare in the year 2040

Bioprinting in regenerative medicine

Proof It’s Possible to Enhance or Suppress Memories

Newly approved Novartis gene therapy will be world’s most expensive drug

How Europe will spend €100 billion in its next research programme

A new study uncovers how we evolved to benefit from eating fermented food

Clinical updates in Regenerative Medicine

Mobile phone app designed to boost physical activity in women shows promise